Evidence map›Paper›PMID 37047987›Full record

ArticleInternational journal of environmental research and public health2023

A Comparison between Perceptions of Psychiatric Outpatients and Psychiatrists Regarding Benzodiazepine Use and Decision Making for Its Discontinuation: A Cross-Sectional Survey in Japan.

Yumi Aoki, Masahiro Takeshima, Takashi Tsuboi, Eiichi Katsumoto, Ken Udagawa, Ken Inada, Koichiro Watanabe, Kazuo Mishima, Yoshikazu Takaesu

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Yumi AokiPsychiatric and Mental Health Nursing, St. Luke's International University, Tokyo 104-0044, Japan.
Masahiro TakeshimaDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita 010-8543, Japan.ORCID 0000-0003-0614-7524
Takashi TsuboiDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo 181-8611, Japan.
Eiichi KatsumotoKatsumoto Mental Clinic, Osaka 543-0056, Japan.ORCID 0000-0001-9417-4391
Ken UdagawaCommunity Mental Health & Welfare Bonding Organization, Chiba 272-003, Japan.
Ken InadaDepartment of Psychiatry, Kitasato University School of Medicine, Kanagawa 252-0374, Japan.
Koichiro WatanabeDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo 181-8611, Japan.
Kazuo MishimaDepartment of Neuropsychiatry, Akita University Graduate School of Medicine, Akita 010-8543, Japan.ORCID 0000-0003-1182-1181
Yoshikazu TakaesuDepartment of Neuropsychiatry, Kyorin University School of Medicine, Tokyo 181-8611, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlthough long-term use of benzodiazepines and z-drugs (BZDs) is not recommended, little is known about the stakeholders' perceptions. This study aimed to assess and compare the perceptions of BZD use and decision making regarding its discontinuation between psychiatric outpatients and psychiatrists.

methodsA cross-sectional survey was conducted.

resultsOf 104 outpatients, 92% were taking hypnotics and 96% were taking anxiolytics for ≥a year, while 49% were willing to taper hypnotic/anxiolytics within a year of starting. Most psychiatrists felt that "patient and psychiatrist make the decision together on an equal basis" compared to patients (

conclusionThe results suggest that the majority of psychiatric outpatients were taking hypnotic/anxiolytics for a long time against their will. There might be a difference in perceptions toward hypnotic/anxiolytic use and decision making for its discontinuation between psychiatric outpatients and psychiatrists. Further research is necessary to fill this gap.

Indexed as

Anti-Anxiety AgentsPsychiatryBenzodiazepinesCross-Sectional StudiesDecision MakingHumansHypnotics and SedativesJapanOutpatientsAnti-Anxiety AgentsBenzodiazepinesHypnotics and Sedativesbenzodiazepinecross-sectional surveyJapanpsychiatric outpatientshared decision makingtreatment decision making

Identifiers

PMID37047987
PMCPMC10094391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.